rized from 1 to 3 in "no", "quite" and "a lot of expectations". The ANOVA test was used to evaluate the impact of the expectations on the measured outcomes. RESULTS: There were 884 patients (360 hips and 524 knees) who replied the two times. In all the physic-functional expectations items patients showed statistically significant improvements in all HRQOL dimensions except in the Mental Component Summary (MCS) of the SF-12, observing an ascending gradient, so the higher the prior-surgery expectations are, the greater the improvement is, at 12 months post-surgery. Regarding the two questions about social expectations, in both of them the results were equal to the physicfunctional expectations in all dimensions. The question about psychological expectations keeps on showing this significant improvement in all the dimensions with the same ascending gradient CONCLUSIONS: Patient expectations prior-surgery were important predictors of improvement outcomes in health related quality of life at 12 months after THR and TKR. 
rized from 1 to 3 in "no", "quite" and "a lot of expectations". The ANOVA test was used to evaluate the impact of the expectations on the measured outcomes. RESULTS: There were 884 patients (360 hips and 524 knees) who replied the two times. In all the physic-functional expectations items patients showed statistically significant improvements in all HRQOL dimensions except in the Mental Component Summary (MCS) of the SF-12, observing an ascending gradient, so the higher the prior-surgery expectations are, the greater the improvement is, at 12 months post-surgery. Regarding the two questions about social expectations, in both of them the results were equal to the physicfunctional expectations in all dimensions. The question about psychological expectations keeps on showing this significant improvement in all the dimensions with the same ascending gradient CONCLUSIONS: Patient expectations prior-surgery were important predictors of improvement outcomes in health related quality of life at 12 months after THR and TKR. A statistically significant correlation was found between HAQ and all the SF-36 scales. Correlation coefficients ranged from -0.471 (GH) to -0.786 (PF) at level 0.01. HAQ was strongly correlated with the mobility (r = 0.531), self-care (r = 0,546), and usual activity (r = 0,513) of the EQ-5D at level 0.05. Cronbach' alpha coefficients for HAQ, SF-36 and EQ-5D were 0.856, 0.879 and 0.552 respectively. CONCLUSIONS: RA patients recorded significantly low levels of HRQL. The study reveals a statistically significant correlation among HAQ, SF-36 and EQ-5D. Clinical fragility fractures, QoL measured by EQ-5D and BP by a Visual Analogue Scale (VAS) and a questionnaire were collected. RESULTS: Among 309 patients enrolled in France, 223 (72.2%) patients completed the 18 month visit. Follow-up data were available for 292 (94.5%) patients. At baseline, mean (SD) age was 74.5 (7.4) years, 96.8% of patients had 2 or more prevalent fractures occurred after age 40, the mean number of fractures (SD) was 4.2 (1.7) and median number was 4.0 (interquartile range 3.0-5.0). During the study, 43 women (14.7%) sustained a total of 48 incident fractures (50.0% clinical vertebral, 50.0% non-vertebral). Between baseline and 18 months visit, EQ-5D Health State Values improved in 63.2% of patients and median (Q1;Q3) values increased from 0.52 (0.03;0.69) to 0.69 (0.52;0.76). Back pain improved between baseline and 18 months visit: Percentage of patients suffering from back pain everyday or almost everyday decreased from 76.6% to 31.4%, moderate or severe back pain from 93.1% to 66.5%, severe activities limitations from 46.9% to 12.6%. Mean back pain intensity (VAS [SD]) decreased from 56.2 (24.9) mm to 34.1 (22.5) mm and was improved in 70.3% of patients who had a baseline intensity over 67 mm. CONCLUSIONS: French patients with osteoporosis were treated with teriparatide. These patients had severe osteoporosis associated with back pain which impacted on daily activities Improved quality of life and back pain were observed during teriparatide treatment and 14.7% of patients had a new fracture.
PMS49 HEALTH-RELATED QUALITY OF LIFE (HRQL) OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS (RA) PATIENTS IN GREECE: PRELIMINARY RESULTS FROM THE HEOR STUDY

Papagiannopoulou
PMS51 MAJOR DETERMINANTS OF EUROQOL (EQ-5D) IN PATIENTS WITH RHEUMATOID ARTHRITIS BASED ON A LARGE JAPANESE COHORT
The University of Tokyo, Bunkyo, Tokyo, Japan, 2 Tokyo women's medical university, Shinjyuku, Tokyo, Japan OBJECTIVES: To maintain good quality of life (QOL) is an important goal in the management of patients with rheumatoid arthritis (RA). Since QOL of RA patients is influenced by many factors, we quantitatively measured QOL of RA patients based on Japanese version of EuroQoL (EQ-5D), and we analyzed the major determinants of EQ-5D in RA patients using a large observational cohort of RA patients in Japan. METHODS: IORRA (Institute Of Rheumatology Rheumatoid Arthritis) is an observational cohort of RA patients established in the Institute of Rheumatology Tokyo Women's Medical University since 2000. Essentially all RA patients who consulted there were registered, and clinical parameters including the disease activity, use of drugs and the occurrence of adverse events in daily clinical settings were assessed biannually based on patient's report, physician's examination and laboratory data. In this cohort, we evaluated QOL of RA patients using EQ-5D, and then analyzed the factors that influenced on EQ-5D by the analysis of variance. The factors analyzed here were gender, age, disease duration, disease activity, disability, and comorbidity. RESULTS: In September 2007, a total 5,023 RA patients (female 84.2%, average 58.0 years-old, average disease duration 11.3 years, rheumatoid factor positive 74.8%, patients taking steroid, methotrexate and biologics were 51.0%, 63.6%, and 4.3%, respectively) answered the questionnaire of EQ-5D. The factors aand the percentage of their contributions on EQ-5D were as follows; i) disability assessed by JHAQ (Japanese Health Assessment Questionnaire): 57.6%, pain VAS (visual analog scale): 12.5%, female: 6.1%, joint surgery: 5.9%, non-orthopedic surgery: 5.4%, duration of disease: 1.8% and occurrence of fractures: 1.3%. CONCLU-SIONS: QOL of RA patients is deeply influenced by the disability together with comorbidity. Management for the control of both disease activity and comorbidity is crucial. PFS, Castres, France OBJECTIVES: The French public health law of 9 August 2004 took this need into consideration and provided for the implementation of a quality of life improvement programme for those affected by chronic illnesses. Furthermore, the 87th of the 110 Public Health objectives is aimed at "Improving the quality of life of those suffering from osteoarthritis" Describe what impact treating sufferers of osteoarthritis has on their quality of life. METHODS: Quality of life was also evaluated for subjects suffering from gonarthritis using the SF-12 score, which is an approved generic tool for determining the physical and mental state of health of populations. RESULTS: A total of 256 subjects suffering from gonarthritis were randomised into 2 groups: 127 randomised subjects were placed in the group treated with ACS Avian, and 129 randomised subjects in the group receiving the placebo. Upon inclusion, the PCS-12 scores were 36.43 and 36.64 for the group treated with ACS Avian and the group receiving the placebo respectively. The 2 groups were similar upon inclusion. After 6 months of treatment, the PCS-12 scores were 42.25 and 39.47 for the group treated with ACS Avian and the group receiving the placebo respectively. There was a statistically significant improvement in the physical dimension score of the group of patients treated with ACS Avian compared with that of the placebo group (p < 0.05). CONCLUSIONS: These various studies confirm the sharp deterioration in the physical dimension of quality of life of patients with gonarthritis. There was a statistically significant improvement in the physical dimension score of the group of patients treated with ACS Avian compared with that of the placebo group. This data confirms the pertinence of both the public health objective fixed by the health authorities, and the use of ACA Avian in the treatment of osteoarthritis.
PMS52 THE QUALITY OF LIFE OF SUFFERERS OF OSTEOARTHRITIS: THE IMPACT OF TREATMENT
PMS53 PUBLIC HEALTH OBJECTIVE:THE QUALITY OF LIFE OF SUFFERERS OF OSTEOARTHRITIS FINALLY TAKEN INTO CONSIDERATION
Taieb C 1 , Roche R 2 1 Pierre Fabre, Boulogne, FRANCE, France, 2 PFS, Castres, France OBJECTIVES: Over the last few years, in addition to traditional mortality and morbidity indexes, new measuring instruments for assessing state of health have been developed. One of the applications of these new instruments is the self-assessment, by patients, of their state of health. Quality of life is therefore readily taken into consideration today when assessing state of health, whether in terms of understanding the consequences of a pathology, comparing the impact of alternative strategies, or evaluating the effect of health policies. The 87th of the 110 public health objectives is aimed at "Limiting the disability and improving the quality of life of those suffering from osteoarthritis" Compare the level of quality of life in sufferers of osteoarthritis with that of the population in general and other pathologies. METHODS: In order to evaluate the quality of life of osteoarthritis patients, SF-12 scores were calculated for 301 patients suffering from femorotibial gonarthritis and 1,945 representative subjects of the French population aged 15 and over. The SF-12 score is a generic tool used to assess the physical and mental state of health of populations. The higher the score, the better the quality of life. RESULTS: The average PCS-12 score was considerably lower in osteoarthritis patients (36.08 Ϯ 7.88) compared with that of the population in general (49.87 Ϯ 8.32). MCS-12 scores were similar for both populations (48.88 Ϯ 10.24 and 46.77 Ϯ 9.69 respectively). There was a strong correlation between PCS-12 scores and those of the Lequesne algofunctional index (p < 0.0001), knee pain at rest (p = 0.0013) and in activity (p < 0.0001). There was a strong correlation between MCS-12 scores and those of the Lequesne index (p < 0.003), and at the limitation of the walking perimeter in particular. For comparison purposes, PCS-12 and MCS-12 scores for an American population were 46.47 and 52.99 respectively for hypertension, 40.02 and 51.15 for a cardiac accident, and 44.84 and 52.49 for type II diabetes. Little SF-12 data exists in France. A study carried out in 2002 on the benign hypertrophy of the prostate (BHP) gave PCS-12 and MCS-12 scores of 46 and 47.2 respectively. CONCLUSIONS: These studies confirm the sharp deterioration in the quality of life of patients with gonarthritis, both compared with the population in general and compared with patients affected by other chronic pathologies. Deterioration of the physical dimension was observed, associated with pain and functional disability. The mental dimension of quality of life seemed less affected, and was associated with the limitation of the walking perimeter. This data confirms the pertinence of the 87th public health objective. (Saris, Vanlauwe et al. 2008) . The SF-36 questionnaire collected along the trial allowed the calculation of utility scores. This analysis aims to quantify the gap in utility levels by surgery outcome. METHODS: Patients were split by response status to the self-reported Knee injury and Osteoarthritis Outcome Score (KOOS) and pain Visual Analog Scale (VAS) regardless of the treatment received. Utility scores were derived from the SF-36 via a validated algorithm and compared between responders (overall KOOS increase >=10%, VAS decrease >=20% vs. baseline) and non-responders at Months 24, 30 and
